Michael Gelband’s Astrana Health ASTH Stock Holding History

Michael Gelband’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$591K	Sell	12,743 -6,408	-33%	-$231K	﹤0.01%	1192
2026 Q1	$470K	Sell	19,151 -80,813	-81%	-$1.91M	﹤0.01%	1204
2025 Q4	$2.48M	Buy	+99,964	New	+$2.65M	0.02%	704
2025 Q3	–	Sell	-8,075	Closed	-$201K	–	2100
2025 Q2	$201K	Sell	8,075 -18,015	-69%	-$507K	﹤0.01%	1315
2025 Q1	$809K	Sell	26,090 -10,060	-28%	-$335K	0.01%	971
2024 Q4	$1.14M	Buy	+36,150	New	+$1.72M	0.01%	906
2023 Q1	–	Sell	-14,499	Closed	-$429K	–	2185
2022 Q4	$429K	Sell	14,499 -26,373	-65%	-$848K	0.01%	1234
2022 Q3	$1.59M	Buy	+40,872	New	+$1.87M	0.02%	908
2020 Q4	–	Sell	-20,361	Closed	-$365K	–	2449
2020 Q3	$365K	Buy	+20,361	New	+$351K	0.01%	1183
2020 Q1	–	Sell	-16,987	Closed	-$313K	–	1721
2019 Q4	$313K	Buy	+16,987	New	+$282K	0.01%	1129
2019 Q2	–	Sell	-11,352	Closed	-$208K	–	1366
2019 Q1	$208K	Buy	+11,352	New	+$218K	0.02%	552

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Michael Gelband's ASTH Position: Q2 2026 in Review

Michael Gelband reduced its Astrana Health (ASTH) stake by 33% in Q2 2026, selling an estimated $231K and leaving 12,743 shares worth $591K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Michael Gelband first reported a position in ASTH in Q1 2019 and has held it in 11 quarters since. The position peaked at $2.48M in Q4 2025. 207 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Michael Gelband held 12,743 shares of Astrana Health worth $591K as of Q2 2026.
Michael Gelband sold 6,408 Astrana Health shares in Q2 2026, an estimated $231K.
Astrana Health made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1192 holding.
Michael Gelband first reported a position in Astrana Health in Q1 2019 and has held it in 11 quarters since.
Michael Gelband's Astrana Health position peaked at $2.48M in Q4 2025.
207 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.